Michael Scolaro

Michael Scolaro

Nov 01, 2017

Group 6 Copy 23
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are American Women of Childbearing Age Changing Their Behaviors in Response to the Zika Virus Outbreak?

    The Zika virus outbreak is an international public health emergency, and is linked to microcephaly and...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Can a rabies vaccination booster save African Wild Dogs?

    Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...

    Backer Badge Funded